SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-010741
Filing Date
2023-04-20
Accepted
2023-04-20 16:05:16
Documents
16
Period of Report
2023-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230420_8k.htm   iXBRL 8-K 31652
2 EXHIBIT 10.1 ex_504205.htm EX-10.1 24953
3 EXHIBIT 10.2 ex_504206.htm EX-10.2 25473
4 EXHIBIT 10.3 ex_504207.htm EX-10.3 12917
  Complete submission text file 0001437749-23-010741.txt   227125

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arch-20230415.xsd EX-101.SCH 3601
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230415_def.xml EX-101.DEF 10449
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230415_lab.xml EX-101.LAB 13928
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230415_pre.xml EX-101.PRE 10440
10 EXTRACTED XBRL INSTANCE DOCUMENT arch20230420_8k_htm.xml XML 2324
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 23833124
SIC: 3841 Surgical & Medical Instruments & Apparatus